
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2024-05-06 | John James(R-MI10) | house | Sale | $1,001 - $15,000 |
| 2023-11-10 | John James(R-MI10) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $5.12B-3.0% | $5.28B+1.8% | $5.18B+6.1% | $4.88B+10.6% | $4.42B |
| Cost of goods sold | $3.35B-3.5% | $3.48B-2.5% | $3.57B+2.9% | $3.47B+16.0% | $2.99B |
| Selling, general and administrative expenses | $805.0M-5.0% | $847.0M+0.8% | $840.0M+8.8% | $772.0M+4.5% | $738.7M |
| Other operating charges | $53.0M-32.9% | $79.0M+182.1% | $28.0M-12.5% | $32.0M-27.3% | $44.0M |
| Research and development expenses | $71.0M-4.1% | $74.0M+0.0% | $74.0M+12.1% | $66.0M+5.8% | $62.4M |
| Amortization of acquired intangibles | $98.0M+6.5% | $92.0M+4.5% | $88.0M-29.6% | $125.0M+3.0% | $121.4M |
| Income from operations | $735.0M+4.1% | $706.0M+20.1% | $588.0M+39.0% | $423.0M-8.5% | $462.4M |
| Interest expense, net | $176.0M-14.1% | $205.0M-3.8% | $213.0M+52.1% | $140.0M+4.3% | $134.2M |
| Other expense, net | $13.0M+160.0% | $5.0M-75.0% | $20.0M-23.1% | $26.0M | — |
| Income before income taxes | $546.0M+10.1% | $496.0M+39.7% | $355.0M+38.1% | $257.0M-24.5% | $340.5M |
| Provision for income taxes | $167.0M+59.0% | $105.0M+22.1% | $86.0M+32.3% | $65.0M-14.6% | $76.1M |
| Net income | $379.0M-3.1% | $391.0M+45.4% | $269.0M+40.1% | $192.0M-27.4% | $264.4M |
| Less: Net income attributable to noncontrolling interests | $1.0M | $0-100.0% | $2.0M | $0-100.0% | $500K |
| Net income attributable to common shareholders | $378.0M-3.3% | $391.0M+46.4% | $267.0M+39.1% | $192.0M-27.2% | $263.9M |
| Basic net income per share (in dollars per share) | $1.8M-1.7% | $1.8M+47.1% | $1.2M+40.7% | $860K-24.6% | $1.1M |
| Diluted net income per share (in dollars per share) | $1.7M-2.2% | $1.8M+47.1% | $1.2M+40.7% | $860K-24.6% | $1.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Axalta outlines $280M-$290M Q2 EBITDA range and reiterates $600M AkzoNobel synergy target
Axalta Coating Systems Ltd. (AXTA) Q1 2026 Earnings Call Transcript
Axalta Coating Systems (AXTA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Axalta (AXTA) Q1 2026 Earnings Call Transcript